Listed

Chemours Co: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 5, 2021 and accepted by EDGAR at May 4, 2021, 18:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$1.44bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$1.14bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-01-01 to 2021-03-31$297.0mus-gaap:GrossProfit
Research and development3 months2021-01-01 to 2021-03-31$24.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-01-01 to 2021-03-31$139.0mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2021-01-01 to 2021-03-31$49.0mus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31$5.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31$96.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31$0.57us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31$0.58us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-31169,050,322 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31$39.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$60.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2021-01-01 to 2021-03-31$41.0mus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2021-03-31$1.01bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$2.79bnus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$7.17bnus-gaap:Assets
Current liabilitiesAt period end2021-03-31$1.50bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$6.32bnus-gaap:Liabilities
Long-term debtAt period end2021-03-31$3.97bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-03-31$23.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2021-03-31$850.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-21-023483. Last ingested by Listed: Nov 5, 2026, 19:57 ET. Listed shows no prices and gives no investment advice.